Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.

Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. Mesenchymal stem cells (MSCs) are under evaluation as a therapy for ischemic cardiomyopathy (ICM). Both autologous and allogeneic MSC therapies are possible; however, their safety and efficacy Read more…

stem cells

Stem Cells  CRISPR gene editing help identify therapeutic targets for neurological disorders

Stem Cells  CRISPR gene editing help identify therapeutic targets for neurological disorders CRISPR-Cas9 technologies and human pluripotent stem cell technologies  help to identify new therapeutic goals for neurological disorders such as schizophrenia and drug addiction.   CRISPR-Cas9 modified stem cells is a universal and high-precision gene editing technology that allows researchers Read more…

stem cell therapy